Description

Request for Information (RFI)/Sources Sought (SS) Notice Requiring Activity Name: The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Subject: This is a non-personal service(s) contract to contract mechanisms to supply a web-based chemoinformatic platform software license. This chemoinformatic platform is required to conduct state-of-the-art chemical research including drug development, chemical reactions, drug metabolism, and knowledge of prior art for intellectual property rights. In accordance with Federal Acquisition Regulation (FAR) 15.201 -Exchange with industry before receipt of proposals, this Sources Sought is for information and planning purposes only and at this time shall not be construed as a solicitation or as an obligation or commitment on the part of the Government nor will the Government pay for information solicited. No evaluation letters and/or results will be issued to the respondents. This Sources Sought Notice is a Market Research tool used to determine the availability and adequacy of potential sources, prior to determining the method of acquisition and issuance of a solicitation. The NAICS code for this requirement is 513210 – Software Publisher DISCLAIMER: This Request for Information (RFI)/Sources Sought (SS) Notice is NOT a Request for Proposals (RFP) or a Request for Quotations (RFQ). This RFI is issued solely for market research information and planning purposes only and does not constitute a solicitation. Responses to the RFI will not be returned. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. No contract will be awarded from this announcement. No reimbursement will be made of any costs to provide information in response to this announcement or any follow-up information requests; responders are solely responsible for all expenses associated with responding to this RFI. Availability of any formal solicitation will be announced under a separate announcement. All information received in response to this RFI will be treated as confidential business information. Submitters should properly mark their responses if the information is confidential. All information received in response to this RFI that is marked Proprietary, will be handled accordingly. At this time, questions concerning the composition and requirements for future solicitation will not be entertained. RFI/SS Notice Response and due date: 29 May 2026, 1000, Eastern Time Background: The purpose of this procurement is to ensure that USAMRIID is provided with a Chemoinformatic platform to research chemical reactions. This platform is required to conduct state-of-the-art chemical research including drug development, chemical reactions, drug metabolism, and knowledge of prior art for intellectual property rights. The requirement supports current and future Defense Threat Reductio…

Classification

Contracting Office

Contacts